ARCHIVES

Pfizer Begins Phase III Trial Of Sunitinib In NSCLC

This article is from The Cancer Letter archive.

Vol. 30 No. 9 | September 28, 2007

Download PDF Visit The Full Archive

Related Articles

Rauscher Explains Reasons for Treatment Switches

May 9, 1975

Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint

November 25, 2011

Breast Cancer Death Rates Improving, NCI Says

May 10, 1996

In Brief: Salmon To Step Down As Center Director; Becker To Relinquish Positions At MDACC

September 4, 1998

ORI Bars Cleveland Researcher From Federal Funding

March 24, 1995

Preyer Supported For Chairmanship

January 26, 1979